DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer

British Journal of Cancer

Volumn 104, Issue 6, 2011, Pages 1013-1019

  Cui, T ^a   Chen, Y ^a   Yang, L ^a   Knosel T ^a   Zoller K ^a   Huber, O ^a   Petersen, I ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

colorectal cancer; DNA methylation; DSC3; p53; prognosis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CADHERIN; DESMOCOLLIN 3; DOXORUBICIN; MESSENGER RNA; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EXON; FEMALE; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; COLORECTAL NEOPLASMS; DESMOCOLLINS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79952699335     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.28     Document Type: Article

References (27)

1. Adachi K, Toyota M, Sasaki Y, Yamashita T, Ishida S, Ohe-Toyota M, Maruyama Reo, Hinoda Y, Saito T, Imai K, Kudo R, Tokino T (2004) Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene 23: 7791-7798 (Pubitemid 39457029)
2. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM (2010) The role of p53 in apoptosis. Discov Med 9: 145-152
3. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649
4. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I (2003) Loss of PDCD4 expression in human lung cancer correlates with tumor progression and prognosis. J Pathol 200: 640-646 (Pubitemid 36987314)
5. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ (2007) DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26: 467-476 (Pubitemid 46122837)
6. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG, Perou CM (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489-500 (Pubitemid 38610250)
7. Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Köllermann J, Miller K, Schrader M (2006) Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res 12: 5040-5046 (Pubitemid 44453329)
8. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N (2010) Colorectal cancer. Lancet 375: 1030-1047
9. Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, Jen J (2007) Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol 38: 276-283 (Pubitemid 46096551)
10. Garrod DR, Merritt AJ, Nie Z (2002) Desmosomal cadherins. Curr Opin Cell Biol 4: 537-545 (Pubitemid 35247735)
11. Hamilton SR, Aaltonen LA (2000) World Health Organization classification of tumors. Pathology & genetics, tumors of the digestive system. IARC: Lyon. 104-106
12. Huber O (2003) Structure and function of desmosomal proteins and their role in development and disease. Cell Mol Life Sci 60: 1872-1890 (Pubitemid 37222584)
13. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993
14. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428 (Pubitemid 34587077)
15. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692 (Pubitemid 46273572)
16. Klus GT, Rokaeus N, Bittner ML, Chen Y, Korz DM, Sukumar S, Schick A, Szallasi Z (2001) Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int J Oncol 19: 169-174
17. Kouzminova N, Lu T, Lin AY (2010) Molecular basis of colorectal cancer. N Engl J Med 362: 1245-1246
18. Kurzen H, Munzing I, Hartschuh W (2003) Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30: 621-630 (Pubitemid 37372350)
19. 0-deoxycytidine for epigenetic therapy of cancer. BMC Cancer 8: 128
20. Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H, Akino K, Ohe-Toyota M, Maruyama Y, Tatsumi H, Imai K, Shinomura Y, Tokino T (2006) Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation. Cancer Res 66: 4574-4583
21. Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodŕguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW (2005) Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 7: 669-680
22. Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW (2003) Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22: 3624-3634 (Pubitemid 36765322)
23. Shames DS, Minna JD, Gazdar AF (2007) DNA methylaion in health, disease, and cancer. Curr Mol Med 7: 85-102 (Pubitemid 46322281)
24. 0 CpG island hypermethylation in human cancers. Cancer Res 60: 4353-4357 (Pubitemid 32103610)
25. Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, Imai K, Sugai T, Shen L, J.Issa J, Shinomura Y, Tokino T, Toyota M (2010) IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 31: 342-349
26. Tselepis C, Chidgey M, North A, Garrod D (1998) Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 95: 8064-8069 (Pubitemid 28326066)
27. Wales MM, Biel MA, Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577